- Home
- SLGL vs ACFN Comparison
SLGL vs ACFN Comparison
Compare SLGL & ACFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- ACFN
- Stock Information
- Founded
- SLGL 1997
- ACFN 1986
- Country
- SLGL Israel
- ACFN United States
- Employees
- SLGL N/A
- ACFN N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- ACFN Military/Government/Technical
- Sector
- SLGL Health Care
- ACFN Consumer Discretionary
- Exchange
- SLGL Nasdaq
- ACFN Nasdaq
- Market Cap
- SLGL 69.1M
- ACFN 76.5M
- IPO Year
- SLGL 2018
- ACFN N/A
- Fundamental
- Price
- SLGL $29.01
- ACFN $28.77
- Analyst Decision
- SLGL
- ACFN
- Analyst Count
- SLGL 0
- ACFN 0
- Target Price
- SLGL N/A
- ACFN N/A
- AVG Volume (30 Days)
- SLGL 25.3K
- ACFN 28.0K
- Earning Date
- SLGL 08-15-2025
- ACFN 11-06-2025
- Dividend Yield
- SLGL N/A
- ACFN N/A
- EPS Growth
- SLGL N/A
- ACFN 1520.82
- EPS
- SLGL N/A
- ACFN 2.84
- Revenue
- SLGL $23,931,000.00
- ACFN $13,202,000.00
- Revenue This Year
- SLGL N/A
- ACFN N/A
- Revenue Next Year
- SLGL $31.17
- ACFN N/A
- P/E Ratio
- SLGL N/A
- ACFN $10.78
- Revenue Growth
- SLGL 264.86
- ACFN 50.98
- 52 Week Low
- SLGL $4.01
- ACFN $17.22
- 52 Week High
- SLGL $30.98
- ACFN $33.00
- Technical
- Relative Strength Index (RSI)
- SLGL 65.45
- ACFN N/A
- Support Level
- SLGL $23.15
- ACFN N/A
- Resistance Level
- SLGL $30.98
- ACFN N/A
- Average True Range (ATR)
- SLGL 2.27
- ACFN 0.00
- MACD
- SLGL 0.00
- ACFN 0.00
- Stochastic Oscillator
- SLGL 74.90
- ACFN 0.00
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.